New England Research & Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tyson Foods
TSN
|
+$935K |
| 2 |
MetLife
MET
|
+$903K |
| 3 |
Fox Class B
FOX
|
+$867K |
| 4 |
Conagra Brands
CAG
|
+$770K |
| 5 |
Elanco Animal Health
ELAN
|
+$663K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$1.8M |
| 2 |
Estee Lauder
EL
|
+$1.41M |
| 3 |
AAWW
Atlas Air Worldwide Holdings, Inc.
AAWW
|
+$1.11M |
| 4 |
MDC
M.D.C. Holdings, Inc.
MDC
|
+$1.09M |
| 5 |
United Airlines
UAL
|
+$915K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.53% |
| 2 | Consumer Staples | 15.56% |
| 3 | Industrials | 14.75% |
| 4 | Technology | 13.52% |
| 5 | Financials | 12.33% |
Similar funds
New England Research & Management's Q3 2019 Portfolio in Review
As of Q3 2019, New England Research & Management held 191 positions worth $138M, down 6.3% from $147M the previous quarter. Its ten largest holdings account for 24% of the portfolio.
New England Research & Management withdrew a net $9.71M in Q3 2019, closing 34 positions and reducing 77 holdings. Its most notable exit was Amgen, an estimated $1.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 20% a quarter earlier, followed by Consumer Staples and Industrials.
Against the trend, New England Research & Management opened a new position in Tyson Foods worth $948K.
- New England Research & Management's largest Q3 2019 buy was Tyson Foods: 11,000 shares worth $948K.
- New England Research & Management added most to Elanco Animal Health in Q3 2019, an estimated $663K increase.
- New England Research & Management's biggest Q3 2019 reduction was Estee Lauder, cutting an estimated $1.41M.
- New England Research & Management fully exited Amgen in Q3 2019, selling an estimated $1.8M.
- New England Research & Management's ten largest holdings make up 24% of its $138M portfolio in Q3 2019.
- New England Research & Management opened 28 new positions and closed 34 in Q3 2019.
- New England Research & Management's portfolio value fell 6.3% quarter-over-quarter to $138M.
Based on New England Research & Management's 13F filing for Q3 2019, filed 4 Nov 2019.